Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
Bio-Rad Diabetes Division

Nucleic Acid Test Rapidly Detects Antibiotic Resistant Staphylococcus

By Labmedica International staff writers
Posted on 02 Jan 2012
A rapid, accurate molecular diagnostic tool can differentiate two important disease-causing Staphylococcus bacteria, while simultaneously determining antibiotic resistance.

The Verigene automated BC-S test provides detection of Staphylococcus aureus, S. epidermidis, and the mecA gene. The mecA gene confers resistance to the antibiotic methicillin/oxacillin. Methicillin-resistant S.aureus (MRSA) bacteremia is associated with a significantly higher mortality rate than methicillin-susceptible S. aureus bacteremia, posing a substantial healthcare burden.

The BC-S test provides species and resistance detection from two types of Gram-positive blood culture bottles within two and a half hours, as compared with current microbiological culture methods, which can take up to 3 days.

Studies have shown that delayed administration of appropriate antibiotics is associated with a 7.6% decrease in survival rate for each hour that therapy is delayed. Rapid molecular testing of blood cultures has been shown to reduce this time, and is associated with hospital cost savings of up to USD 21,000 per patient.

A product of Nanosphere (Alachua, FL, USA), the BC-S test obtained CE-IVD marking for regulatory approval of the full BC-GP test as an in vitro diagnostic in Europe. It has now also received 510(k) clearance from the US Food and Drug Administration (FDA; Silver Spring, MD, USA) as the first phase of a stepwise process to obtain clearance for a larger test panel, which will be marketed as the Verigene BC-GP test.

The BC-S test expands Nanosphere's infectious disease test capabilities to include the rapid detection of bacteria that cause deadly bloodstream infections.

Related Links:

Nanosphere
US Food and Drug Administration




KARL HECHT GMBH & CO KG
DIASYS DIAGNOSTIC SYSTEMS
77 ELEKTRONIKA

Channels

Hematology

view channel

Magnetic Resonance Improves Approach to Measuring Hemostasis Parameters

Two studies evaluating a magnetic resonance based detector for hemostasis measurements found its multiplex results to be rapid and accurate using lower blood volumes. At the International Society on Thrombosis and Hemostasis (ISTH) 2015 Congress (Toronto, Canada), T2 Biosystems, Inc. (Lexington, MA, USA) presented results... Read more

Lab Tech.

view channel
Image: Verigene System instrumentation consists of a Verigene Reader and one or multiple Verigene Processor SPs (Photo courtesy of Nanosphere).

Directed Molecular Diagnostic Tests Highlight Recent Microbiology Conference

The performance of a series of directed molecular diagnostic tests was confirmed by several studies presented at a recent microbiology conference. Nanosphere (Northbrook, IL, USA) manufactures tests... Read more

Industry News

view channel

QIAGEN Expands Diagnostics Menu in Partnership with Seegene

In a new collaboration, Seegene Inc. (Soul, Republic of Korea) will use its proprietary next-generation qPCR technology in developing new multiplex assays for the flagship platform of Qiagen NV (Venlo, Netherlands and Hilden, Germany). Seegene will develop a menu of multiplex assay panels for the modular QIAsymphony... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.